Connect with us

Hi, what are you looking for?

[t4b-ticker]

India

Bharat Biotech Dossier Under Evaluation for Covaxin Emergency Use Listing, Says WHO

New Delhi: World Health Organisation (WHO) Officials had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker’s dossier for Emergency Use Listing (EUL) of Covaxin is currently under review by the technical experts for consideration, WHO South-East Asia Regional Director Dr Poonam Khetrapal Singh said on Monday.

Delhi Govt has directed all hospitals to administer Covaxin only to the eligible recipients in 18-44 year age group (PTI File Image)
A health worker with Bharat Biotech's COVID-19 Vaccine shot (PTI photo)

New Delhi: World Health Organisation (WHO) Officials had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker’s dossier for Emergency Use Listing (EUL) of Covaxin is currently under review by the technical experts for consideration, WHO South-East Asia Regional Director Dr Poonam Khetrapal Singh said on Monday.

During her recent chat with ANI, Dr Singh also revealed that India has been offered 7.5 million doses of Moderna Covid vaccine through WHO’s COVID-19 Vaccines Global Access (COVAX) program.

The WHO Regional Director then went on to add, “Pfizer, AstraZeneca, Moderna, Johnson and Johnson, Sinovac and Sinopharm have been granted EUL by the WHO. For COVXIN, an expression of interest for EUL has been made to WHO by Bharat Biotech. WHO has already conducted a pre-submission meeting with the company following which a dossier has been submitted by Bharat Biotech to WHO in early July. The dossier is currently under review by the technical experts for consideration of EUL.”

ALSO READ: Current Covid Vaccines Effective Against Delta Variant as per ICMR Studies: Dr NK Arora

Expressing her thoughts over the possibility of the COVID-19 Delta variant becoming the most dominant strain, Dr Singh said, “Delta variant has spread to over 100 countries, the way its spreading is likely to soon become the most dominant COVID strain globally.”

“Among all variants of concern, Delta spreads most rapidly. The rapid spread means more cases, leading to more pressure on health systems and more deaths,” she added.

The WHO South-East Asia director further said that COVID-19 cases and fatalities were again increasing on the global stage.

ALSO READ: Azithromycin No More Effective Against Covid-19 Than Placebo: Study

“The more we allow the virus to spread, the more it will evolve, resulting in more variants. We need to ensure that public health and social measures are implemented continuously. The interventions proven to be effective even against the delta variant,” she said.

(With ANI Inputs)

You May Also Like

Cricket

Kohli only opted to relinquish from T20 leadership and ignored Shastri’s advice of also leaving the ODI captaincy.

India

While the UK has approved Covishield, it has raised concerns over 'vaccine certification' in India.

India

Amarinder Singh also took on the newly elected chief minister, Charanjit Singh Channi, and questioned his promises of free water and power to the...

India

Chief Justice N.V. Ramana has made strong observations about how the sedition law is being misused to curtail free speech, but the Supreme Court...

Advertisement